Chemobrain, Olfactory and Lifestyle Assessment in Onco-Geriatrics: Sex-Mediated Differences between Chemotherapy and Immunotherapy.
Sara InvittoMariangela LeucciGiuseppe AccogliAndrea SchitoClaudia NestolaVincenzo CiccareseRosaria RinaldiPaolo Boscolo RizzoGiacomo SpinatoSilvana LeoPublished in: Brain sciences (2022)
A possible link between chemotherapy and cognitive impairment has been identified. In the literature, this condition is usually called chemobrain and can mostly affect some memory domain but can lead also to other cognitive impairments. Olfaction, which is known to be linked with cognitive domain and the nociception system, can also be affected by chemotherapy. The aim of this study was to investigate the main cognitive and olfactory abilities and the functional and nutritional state of a cohort of chemotherapy and immunotherapy onco-geriatric patients and control geriatrics subjects. Cognitive, olfactory, geriatric and nutritional assessments were performed through the Mini Mental State Examination (MMSE), Sniffin' Sticks Screening 12, G8 test and a questionnaire on the adherence of the Mediterranean diet, respectively. Our findings show a gender effect on the MMSE. Overall results indicate more pronounced impairments both at the cognitive and frailty level regardless of the type of therapy. On the other hand, the Sniffin' Sticks performances highlight a significant decrease in olfactory perception ability of subjects following immunotherapy. Significant correlations between olfactory performance and MMSE and G8 scores were also found, as well as between MMSE and G8 measures.
Keyphrases
- locally advanced
- cognitive impairment
- end stage renal disease
- systematic review
- mental health
- chronic kidney disease
- squamous cell carcinoma
- stem cells
- cardiovascular disease
- metabolic syndrome
- type diabetes
- radiation therapy
- rectal cancer
- peritoneal dialysis
- bone marrow
- hip fracture
- insulin resistance
- glycemic control
- clinical evaluation